NIFTY
90.20  0.95%
 9580.30
S&P BSE SENSEX
223.51  0.69%
 32424.1
Cipla Ltd.
NSE : CIPLA BSE : 500087 ISIN code : INE059A01026
on 29-May-2020
NSE
19.8    3.15%
Rs. 648.15
 
Days Low
Rs. 632.05
Days High
Rs. 651

Open Rs. 635
 
52 week Low
Rs. 356.75
52 week High
Rs.651
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.647.60
19.3    3.07%
on 29-May-2020
BSE
19.3    3.07%
Rs. 647.60
 
Days Low
Rs. 631
Days High
Rs. 650.95

Open Rs. 633
 
52 week Low
Rs. 355.3
52 week High
Rs.650.95
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.648.15
19.8    3.15%
 
 
Last Price (Rs.)  647.60 Value  504573800.00
Net Change (Rs.)  19.30 Best Buy  0.00
Volume  781715 Best Sell  0.00
Prev.Close (Rs.)  628.30 Best Quantity  0
Open (Rs.)  635.00 Sell Quantity  0
High (Rs.)  651.00 52-Week High (Rs.)  651.00
Low (Rs.)  632.05 52-Week Low (Rs.)  356.75
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  522120.53
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1611.40 1610.20 1609.00 
Share Capital1611.40 1610.20 1609.00 
Share Capital1611.40 1610.20 1609.00 
Share Capital1611.40 1610.20 1609.00 
Share Capital1611.40 1610.20 1609.00 
Currents Investments20115.80 10397.40 6381.80 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 475.45 1140764 101.68 139.69 0.21
Dr. Reddys Lab 4073.80 676952 914.23 52.94 0.61
Divis Lab 2395.75 635996 280.36 47.72 0.67
Aurobindo Pharma 745.05 436554 213.23 28.54 0.34
Biocon 354.70 425640 62.81 43.19 0.28
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2020Dec 2019Sep 2019
Net Sales31334.4029262.0033701.80
Operating Profit8782.105102.2010807.00
PBDT8689.705006.7010708.30
Net Profit6045.702822.207373.80
More> 
 
Company News
5/30/2020 12:00:00 AM
Cipla reports 33% fall in Q4 consolidated net profit
5/21/2020 12:00:00 AM
Cipla, Tata Power and Natco Pharma to see some action today
5/21/2020 12:00:00 AM
Cipla gets USFDA’s final approval for Dihydroergotamine Mesylate Nasal...
More>
 
Ratios
   Earnings Per Share (Rs)23.44 
   Book NAV/Share(Rs)195.35 
   PAT Margin (%)14.48 
   Asset Turnover(x)0.74 
   PER(x)22.58 
   Yield(%)0.57 
   EV/Core EBITDA(x)13.83 
   M Cap / Sales3.45 
   Net Sales Growth(%)8.64 
   PAT Growth(%)28.59 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)4.00 
   Quick Ratio(x)2.79 
   Total Debt/Mcap(x)0.00 
More>